SIDHE Institute Launches Groundbreaking Research and Transformative Programs Merging Ancient Wisdom with Modern Science to ...

The microbiome communicates with the gut, the brain and the immune system using microbial metabolites such as short-chain ...

Aston University and Women and Children’s Hospital developing new devices to improve drug treatment 26 November 2024 | Birmingham, UKThe new device is designed to reduce the risk of injuries when ...

ROCKVILLE, MD / ACCESSWIRE / November 26, 2024 / Dr. Roy Rubinfeld, an internationally renowned corneal surgeon and innovator, has developed a groundbreaking epithelium-on corneal cross-linking ...

Policy Recommendations to Reduce the Burden of COPD, calling for solutions to tackle the urgent challenge of chronic obstructive pulmonary disease (COPD), affecting 2% of the UK population, with many ...

NESS ZIONA, ISRAEL / ACCESSWIRE / November 26, 2024 / Enlivex Therapeutics Ltd. (Nasdaq:ENLV)(the "Company"), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

The former Clemson center, now with the Denver Nuggets, says ultrasound treatment with the sam® sustained acoustic medicine device from ZetrOZ Systems helps him recover faster and stay on the court.

Semaglutide being investigated for applications in heart disease, Alzheimer's, liver disease, and moreGLP-1 drugs expected to generate multi-hundreds of billions of revenues in the years to come ...

Aptevo's Peter Pavlik, PhD, to chair a session on "Bi and Multispecific Biologics" and will also give talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR™ ...

Princeton Health Magazine features Dr. Yamasaki on modern approaches to treating Bell's Palsy. PRINCETON, NEW JERSEY / ACCESSWIRE / November 26, 2024 / Dr. Alisa Yamasaki, a board-certified facial ...

SAN DIEGO, CA / ACCESSWIRE / November 26, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...